Order Article Reprints

Li H, Li K, Shu D, Shen M, Tan Z, Zhang W, Pu D, Tan W, Tang Z, Jin A, et al. MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer. Life. 2022; 12(10):1461. https://doi.org/10.3390/life12101461

Li, Han, Kang Li, Dan Shu, Meiying Shen, Zhaofu Tan, Wenjie Zhang, Dongyao Pu, Wenhao Tan, Zhenrong Tang, Aishun Jin, and et al. 2022. "MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer" Life 12, no. 10: 1461. https://doi.org/10.3390/life12101461

Li, H., Li, K., Shu, D., Shen, M., Tan, Z., Zhang, W., Pu, D., Tan, W., Tang, Z., Jin, A., & Liu, S. (2022). MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer. Life, 12(10), 1461. https://doi.org/10.3390/life12101461